Carboxylesterase

Suppliers

Names

[ CAS No. ]:
9016-18-6

[ Name ]:
Carboxylesterase

[Synonym ]:
1,3-Naphthalenediol, 2-[3-(decahydro-2-naphthalenyl)propyl]-4-nitroso-
2-[3-(Decahydro-2-naphthalenyl)propyl]-4-nitroso-1,3-naphthalenediol

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
566.7±20.0 °C at 760 mmHg

[ Molecular Formula ]:
C23H29NO3

[ Molecular Weight ]:
367.481

[ Flash Point ]:
296.5±21.8 °C

[ Exact Mass ]:
367.214752

[ LogP ]:
7.36

[ Vapour Pressure ]:
0.0±1.6 mmHg at 25°C

[ Index of Refraction ]:
1.649

[ Storage condition ]:
2-8°C

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Articles

Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula.

Mol. Biosyst. 9(3) , 375-85, (2013)

Traditional Chinese Medicine (TCM) remedies are composed of different chemical compounds. To understand the underlying pharmacological basis, we need to explore the active components, which function s...

Vascular smooth muscle cells isolated from adipose triglyceride lipase-deficient mice exhibit distinct phenotype and phenotypic plasticity.

Biochem. Biophys. Res. Commun. 434(3) , 534-40, (2013)

The alteration of triglyceride (TG) metabolism in vascular smooth muscle cells (SMC) is likely to be correlated with certain phenotype, though this has not been elucidated. Adipose triglyceride lipase...

Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.

Stem Cells Transl. Med. 2(12) , 983-92, (2013)

CPT-11 (irinotecan) has been investigated as a treatment for malignant brain tumors. However, limitations of CPT-11 therapy include low levels of the drug entering brain tumor sites and systemic toxic...


More Articles


Related Compounds

  • Carboxylesterase-IN-1
  • Pancreatic lipase/Carboxylesterase 1-IN-1
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
  • N-(cyclopropylmethyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine